Hrt Financial LP Sutro Biopharma, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.27 - $5.65 $39,426 - $68,122	12,057 New	12,057 $68,000
Q2 2022 Aug 12, 2022	BUY	$3.41 - $8.95 $552,440 - $1.45 Million	162,006 New	162,006 $844,000
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $306,353 - $602,861	-39,377 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $561,122 - $926,540	39,377 New	39,377 $585,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.